z-logo
open-access-imgOpen Access
Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases
Author(s) -
Chongyang Zhang,
Chen Yan
Publication year - 2020
Publication title -
journal of cellular immunology
Language(s) - English
Resource type - Journals
ISSN - 2689-2812
DOI - 10.33696/immunology.2.045
Subject(s) - vinpocetine , vinca , dementia , medicine , vinca alkaloid , traditional medicine , population , regimen , pharmacology , surgery , environmental health , disease , chemotherapy , vincristine , cyclophosphamide
Vinpocetine is a derivative of vincamine. It has been used to prevent and treat cerebrovascular disorders such as stoke and dementia, and remains widely available in dietary supplements that often marketed as nootropics. Due to its excellent safety profile at therapeutic dose regimen, vinpocetine has raised research interest in its new applications in various experimental disease models. Here we review recent studies that uncovered novel functions of vinpocetine in cardiovascular diseases, including atherosclerosis, obesity, neointimal hyperplasia, vasoconstriction, pathological cardiac remodeling and ischemia stroke. Molecular mechanisms underlined the protective effects of vinpocetine are also discussed. These novel findings may suggest a broadened usage of vinpocetine against relevant cardiovascular diseases in human.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom